The mortality rate for malignant neoplasms of the colon, rectum, and anus among women in the US is projected to decline steadily from 12.3 deaths per 100,000 women in 2024 to 11.0 in 2028. This indicates a downward trend in standardized mortality rates, with the rate decreasing by approximately 2.6% annually over the five-year forecast period.

Future trends to watch for:

Advancements in early detection and treatment methods which may further reduce mortality rates.
The impact of public health initiatives focusing on prevention, such as lifestyle modifications and screening programs.
Changes in healthcare policy and access to treatment which could influence future mortality statistics.